Amazon has received permission from the Food and Drug Administration to conduct tests for the coronavirus, which were developed by its subsidiary STS Lab Holdco, which it hopes to use to enhance its employee screening program, according to the verege.
The test is performed using a self-administered nasal swab that can be performed either under the supervision of a healthcare provider or as part of a home kit where the patient takes their sample and mails it to a central laboratory.
Amazon plans to use the test among its employees as part of its coronavirus preparedness and response program, according to a document from the Food and Drug Administration. Staff may be scheduled to take an on-site test or given a collection kit to administer the test at home.
Under this order, some Amazon employees are automatically granted test dates approximately every 14 days. Amazon has partnered with a third-party healthcare provider who will issue the necessary prescriptions and individual test orders that will be voluntary.
Sibay was hired by Amazon to build its in-house laboratory for testing for COVID-19, Business Insider reported. Last October, the company said it had the infrastructure to run tens of thousands of tests for employees every day.
The new test is a modification of another COVID-19 test conducted by BGI Genomics, which the report said Amazon used at the end of August.
Amazon began selling genomic company DxTerity COVID-19 at-home test kits in January for $ 110.
The company continues to expand in the healthcare field. Last week it announced that it would start offering its telehealth and home healthcare program to other companies.